Two Sigma Investments, LP Invitae Corp Call Options Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $426,300 - $831,430	-29,000 Reduced 53.7%	25,000 $382,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $350,064 - $483,840	14,400 Added 36.36%	54,000 $1.54 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $686,167 - $1.06 Million	-26,300 Reduced 39.91%	39,600 $1.34 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $1.76 Million - $3.03 Million	53,300 Added 423.02%	65,900 $2.52 Million
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $358,218 - $562,842	12,600 New	12,600 $546,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.